Tech and Market Highlights: On Semiconductor Soars, Teslas Steady Growth, and More
Generado por agente de IAAinvest Market Brief
lunes, 29 de julio de 2024, 6:30 pm ET1 min de lectura
C--
ON--
RMD--
1. On Semiconductor (Nasdaq: ON)
On Semiconductor surged by 11.54%. On Semiconductor reported second-quarter fiscal 2024 results, with adjusted EPS of $0.96 surpassing analyst expectations of $0.92. Susquehanna maintains a positive rating with a $95.00 price target, while Citigroup downgraded the stock to neutral, setting a $77.00 price target.
2. Resmed (NYSE: RMD)
Resmed gained solidly by 5.85%. ResMed reported Q3 2024 revenue of $3.462 billion, up 11.65% year-over-year, with a net profit of $729 million. RBC Capital maintains Sector Perform on ResMed with a $204 target. Oppenheimer and Citigroup downgraded ResMed to Perform and Neutral, respectively. Insider transactions were disclosed in July.
3. Tesla (Nasdaq: TSLA)
Tesla gained solidly by 5.6%. Tesla released its mid-2024 report, showing a revenue of $46.801 billion, down 3.02% year-on-year, and a net profit of $26 billion. Morgan Stanley reiterated an Overweight rating with a $310 price target. Tesla may reapply for insurance brokerage registration in China.
4. Mcdonald'S (NYSE: MCD)
Mcdonald'S gained solidly by 3.76%. TD Cowen reiterates buy rating for McDonald's with a target price of $285. Wedbush maintains outperform rating with a target of $295. McDonald's Q2 2024 revenue dropped to $64.9 billion from last year's $65 billion, marking the first decline since 2020.
5. Alibaba Group Holding Limited (NYSE: BABA)
Alibaba Group Holding Limited gained mildly by 2.76%. Chinese companies are seizing new opportunities amid the Paris Olympics. Ctrip reported a 114% YOY increase in travel orders for Paris. Alibaba's presence is prominent at the games, with significant advertising visibility and exports through Alibaba International Station. Jefferies maintains a "buy" rating for Alibaba.
On Semiconductor surged by 11.54%. On Semiconductor reported second-quarter fiscal 2024 results, with adjusted EPS of $0.96 surpassing analyst expectations of $0.92. Susquehanna maintains a positive rating with a $95.00 price target, while Citigroup downgraded the stock to neutral, setting a $77.00 price target.
2. Resmed (NYSE: RMD)
Resmed gained solidly by 5.85%. ResMed reported Q3 2024 revenue of $3.462 billion, up 11.65% year-over-year, with a net profit of $729 million. RBC Capital maintains Sector Perform on ResMed with a $204 target. Oppenheimer and Citigroup downgraded ResMed to Perform and Neutral, respectively. Insider transactions were disclosed in July.
3. Tesla (Nasdaq: TSLA)
Tesla gained solidly by 5.6%. Tesla released its mid-2024 report, showing a revenue of $46.801 billion, down 3.02% year-on-year, and a net profit of $26 billion. Morgan Stanley reiterated an Overweight rating with a $310 price target. Tesla may reapply for insurance brokerage registration in China.
4. Mcdonald'S (NYSE: MCD)
Mcdonald'S gained solidly by 3.76%. TD Cowen reiterates buy rating for McDonald's with a target price of $285. Wedbush maintains outperform rating with a target of $295. McDonald's Q2 2024 revenue dropped to $64.9 billion from last year's $65 billion, marking the first decline since 2020.
5. Alibaba Group Holding Limited (NYSE: BABA)
Alibaba Group Holding Limited gained mildly by 2.76%. Chinese companies are seizing new opportunities amid the Paris Olympics. Ctrip reported a 114% YOY increase in travel orders for Paris. Alibaba's presence is prominent at the games, with significant advertising visibility and exports through Alibaba International Station. Jefferies maintains a "buy" rating for Alibaba.
Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios